Differential expression of tenascin in the skin during hapten-induced dermatitis
- PMID: 8897067
- DOI: 10.1007/BF02473236
Differential expression of tenascin in the skin during hapten-induced dermatitis
Abstract
Tenascin is a large extracellular matrix glycoprotein which is found in limited regions of normal adult tissues including the skin. We investigated the induction of tenascin expression in mouse skin during hapten-induced dermatitis. In the dorsal skin, hapten application first induced a transient expression of tenascin in deeper regions of the skin. Its distribution then spread over the whole dermis corresponding to the infiltration of Mac-2-positive macrophages. In the ear, tenascin was consistently found in the subcutaneous tissue on the inner side, but very little was seen on the outer side. Tenascin did appear transiently, however, on both sides under hapten treatment. In the early phase of allergic contact dermatitis, no apparent induction of tenascin expression was observed in the swollen ear. However, there was an abundant tenascin expression on both sides during healing. Tenascin expressed under normal conditions was mostly the 180-kDa isoform, while the 230-kDa isoform was markedly induced during healing of the dermatitis. These results suggest that tenascin, particularly the larger 230-kDa isoform, may play important roles in the pathogenesis and healing of hapten-induced dermatitis.
Similar articles
-
Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse.J Invest Dermatol. 1998 Dec;111(6):930-5. doi: 10.1046/j.1523-1747.1998.00401.x. J Invest Dermatol. 1998. PMID: 9856798
-
Spatiotemporal changes of fibronectin, tenascin-C, fibulin-1, and fibulin-2 in the skin during the development of chronic contact dermatitis.J Invest Dermatol. 1999 Dec;113(6):906-12. doi: 10.1046/j.1523-1747.1999.00802.x. J Invest Dermatol. 1999. PMID: 10594729
-
The Role of Interleukin-19 in Contact Hypersensitivity.Biol Pharm Bull. 2018;41(2):182-189. doi: 10.1248/bpb.b17-00594. Biol Pharm Bull. 2018. PMID: 29386478
-
The tenascin-C knockout revisited.J Cell Sci. 1999 Nov;112 ( Pt 22):3847-53. doi: 10.1242/jcs.112.22.3847. J Cell Sci. 1999. PMID: 10547346 Review.
-
Expression and immune function of tenascin-C.Crit Rev Immunol. 2011;31(2):115-45. doi: 10.1615/critrevimmunol.v31.i2.30. Crit Rev Immunol. 2011. PMID: 21542790 Review.
Cited by
-
Elongated dermatan sulphate in post-inflammatory healing skin distributes among collagen fibrils separated by enlarged interfibrillar gaps.Biochem J. 2001 Aug 15;358(Pt 1):157-63. doi: 10.1042/0264-6021:3580157. Biochem J. 2001. PMID: 11485563 Free PMC article.
-
Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype.Cancer Immunol Res. 2020 Mar;8(3):368-382. doi: 10.1158/2326-6066.CIR-19-0276. Epub 2020 Jan 15. Cancer Immunol Res. 2020. PMID: 31941671 Free PMC article.
-
Proof of Concept Study for Increasing Tenascin-C-Targeted Drug Delivery to Tumors Previously Subjected to Therapy: X-Irradiation Increases Tumor Uptake.Cancers (Basel). 2020 Dec 5;12(12):3652. doi: 10.3390/cancers12123652. Cancers (Basel). 2020. PMID: 33291427 Free PMC article.
-
Meniscal Tissue Engineering Using Aligned Collagen Fibrous Scaffolds: Comparison of Different Human Cell Sources.Tissue Eng Part A. 2018 Jan;24(1-2):81-93. doi: 10.1089/ten.TEA.2016.0205. Epub 2017 Jun 13. Tissue Eng Part A. 2018. PMID: 28463545 Free PMC article.
-
Core-Shell Nanofibrous Scaffolds for Repair of Meniscus Tears.Tissue Eng Part A. 2019 Dec;25(23-24):1577-1590. doi: 10.1089/ten.TEA.2018.0319. Epub 2019 Aug 14. Tissue Eng Part A. 2019. PMID: 30950316 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources